PROTAGONIST THERAPEUTICS INC's ticker is PTGX and the CUSIP is 74366E102. A total of 145 filers reported holding PROTAGONIST THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.11 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $885,374 | -44.4% | 53,080 | -7.9% | 0.00% | -50.0% |
| Q2 2023 | $1,592,238 | +39.3% | 57,648 | +16.0% | 0.00% | 0.0% |
| Q1 2023 | $1,143,422 | +106.7% | 49,714 | -1.9% | 0.00% | +100.0% |
| Q4 2022 | $553,159 | +32.3% | 50,702 | +2.3% | 0.00% | 0.0% |
| Q3 2022 | $418,000 | +5.8% | 49,567 | -0.7% | 0.00% | 0.0% |
| Q2 2022 | $395,000 | -70.2% | 49,938 | -10.9% | 0.00% | -50.0% |
| Q1 2022 | $1,327,000 | -35.8% | 56,052 | -7.3% | 0.00% | 0.0% |
| Q4 2021 | $2,068,000 | +106.6% | 60,465 | +7.0% | 0.00% | +100.0% |
| Q3 2021 | $1,001,000 | -60.9% | 56,508 | -0.9% | 0.00% | -66.7% |
| Q2 2021 | $2,558,000 | +85.9% | 57,003 | +7.3% | 0.00% | +50.0% |
| Q1 2021 | $1,376,000 | +43.3% | 53,123 | +11.5% | 0.00% | +100.0% |
| Q4 2020 | $960,000 | +7.1% | 47,624 | +3.9% | 0.00% | 0.0% |
| Q3 2020 | $896,000 | +49.1% | 45,846 | +34.7% | 0.00% | 0.0% |
| Q2 2020 | $601,000 | +216.3% | 34,044 | +26.8% | 0.00% | – |
| Q1 2020 | $190,000 | +1.6% | 26,856 | +1.2% | 0.00% | – |
| Q4 2019 | $187,000 | -41.4% | 26,542 | 0.0% | 0.00% | -100.0% |
| Q3 2019 | $319,000 | +12.7% | 26,542 | +13.7% | 0.00% | 0.0% |
| Q2 2019 | $283,000 | +87.4% | 23,347 | +32.6% | 0.00% | – |
| Q1 2018 | $151,000 | -59.6% | 17,613 | -2.0% | 0.00% | -100.0% |
| Q4 2017 | $374,000 | +37.5% | 17,965 | +16.7% | 0.00% | 0.0% |
| Q3 2017 | $272,000 | +44.7% | 15,400 | -7.2% | 0.00% | – |
| Q2 2017 | $188,000 | -4.1% | 16,600 | +8.5% | 0.00% | – |
| Q1 2017 | $196,000 | -43.2% | 15,300 | -2.5% | 0.00% | -100.0% |
| Q4 2016 | $345,000 | +1.5% | 15,700 | -2.5% | 0.00% | 0.0% |
| Q3 2016 | $340,000 | – | 16,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 2,449,183 | $19,373,000 | 4.95% |
| Bain Capital Life Sciences Investors, LLC | 2,260,572 | $17,881,000 | 2.10% |
| Finepoint Capital LP | 735,126 | $5,815,000 | 2.01% |
| Altium Capital Management LP | 365,100 | $2,888,000 | 1.16% |
| RTW INVESTMENTS, LP | 4,794,499 | $37,924,000 | 0.98% |
| Amitell Capital Pte Ltd | 50,129 | $397,000 | 0.90% |
| COWEN AND COMPANY, LLC | 1,065,724 | $8,430,000 | 0.81% |
| Tri Locum Partners LP | 155,000 | $1,226,000 | 0.50% |
| BVF INC/IL | 1,106,838 | $8,755,000 | 0.42% |
| HighVista Strategies LLC | 46,459 | $367,000 | 0.22% |